CIK 0001788028 · <br>Emerging growth company
Jasper Therapeutics, Inc.
Sign in to watch- Ticker
- JSPR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 842984849
- Phone
- 6505491400
- Business address
- 2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA, 94065
- Former names
- Amplitude Healthcare Acquisition Corp
- 424B3 Offering Prospectus
- S-4/A Deal Registration Statement - Business Combination
- CORRESP Other Correspondence Between Filers and SEC Staff
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- UPLOAD Other SEC-generated Letter
- 10-Q Report Quarterly Report
- S-4/A Deal Registration Statement - Business Combination
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- 10-Q/A Report 10-Q/A
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- 10-Q/A Report 10-Q/A
- 10-K/A Report 10-K/A
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 20 of 25 · 484 filings